Sponsor
Chelsea and Westminster NHS Foundation Trust
Clinical research sponsor
Clinical trials
26 shownEfficacy of Doravirine + Dolutegravir Dual Therapy in the Context of Antiretroviral Therapy SwitchNCT04892654 · lead sponsor · 2022-08-17
RECRUITINGEffect of Obesity, Diabetes and Bariatric Surgery on Pregnancy OutcomesNCT05753124 · lead sponsor · 2015-05-01
RECRUITINGThe Effect on Lipid Profile of Switching to Delstrigo in HIV Positive PatientsNCT05289986 · lead sponsor · 2023-11-21
TERMINATEDPhysiological and Environmental Data in a Remote Setting to Predict Exacerbation Events in Patients With Chronic Obstructive Pulmonary DiseaseNCT06118632 · lead sponsor · 2023-09-22
TERMINATEDEfficacy, Tolerability and Acceptability of Biktarvy by TPLWHNCT04944654 · lead sponsor · 2023-01-07
TERMINATEDThe Effect of Biktarvy (B/F/TAF) on Whole-body Insulin Sensitivity, Lipid and Endocrine Profile in Healthy VolunteersNCT04950530 · lead sponsor · 2022-12-22
COMPLETEDThe Effect of Dolutegravir on Whole-body Insulin Sensitivity, Lipid and Endocrine Profile in Healthy VolunteersNCT04771754 · lead sponsor · 2022-03-20
COMPLETEDEfficacy of BIC/F/TAF Versus Standard of Care in the Treatment of New HIV Infection Diagnoses in the Context of 'Test and Treat'NCT04653194 · lead sponsor · 2020-09-30
COMPLETEDTrans People Living With HIV Throughout EuropeNCT03922269 · lead sponsor · 2019-10-11
COMPLETEDPharmacokinetics of Plasma Doravirine Once Daily Over 72 Hours Following Drug Intake Cessation in Healthy VolunteersNCT03894124 · lead sponsor · 2019-06-12
COMPLETEDAerogen Nebuliser Versus Standard Nebulised Therapy in Acute Chronic Obstructive Pulmonary DiseaseNCT02379065 · lead sponsor · 2015-02-01
COMPLETEDPRIME: Cognitive Outcome Following Major BurnsNCT03242395 · lead sponsor · 2014-10-01
COMPLETEDBronchoscopic Intrabullous Autologous Blood Instillation (BIABI) for EmphysemaNCT01727037 · lead sponsor · 2012-10-01
UNKNOWNHIV Indicator Diseases Survey Across Europe - UK ArmNCT01196468 · lead sponsor · 2010-07-01
UNKNOWNHIV Testing in Non-traditional Settings StudyNCT01138878 · lead sponsor · 2009-07-01
COMPLETEDBiomarkers for Post-treatment Control in HIV: International Study of the EU2Cure Research Consortium (Phase I)NCT07692295 · collaborator · 2026-10-01
NOT_YET_RECRUITINGExploring a Digital HIV Onward Disclosure Intervention, in People Living With HIV of Sub-Saharan African Ethnicity.NCT05804968 · collaborator · 2023-07-01
UNKNOWNA Prophylactic HIV Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Clade C DREP Alone and in Combination With a Clade C ENV Protein in Healthy HIV-uninfected AdultsNCT04844775 · collaborator · 2022-08-05
COMPLETEDImplementing Long-Acting Novel AntiretroviralsNCT05294159 · collaborator · 2022-07-18
COMPLETEDA HIV Vaccine Trial in Individuals Who Started Antiretrovirals During Primary or Chronic Infection (EHVA T02)NCT04120415 · collaborator · 2022-06-21
COMPLETEDOPEN Feasibility StudyNCT03584412 · collaborator · 2018-07-09
UNKNOWNGenetic Determinants of Kidney Disease in People of African Ancestry With HIVNCT05685810 · collaborator · 2018-05-01
ACTIVE_NOT_RECRUITINGOPEN Study: Pain Management Treatment Needs InterviewsNCT02972606 · collaborator · 2016-11-01
COMPLETEDResearch In Viral Eradication of HIV ReservoirsNCT02336074 · collaborator · 2015-11-27
COMPLETEDThe Intensive Pharmacokinetics Sub-study of Encore1 (ENCORE1-PK)NCT01271894 · collaborator · 2011-09-01
COMPLETEDHIV Reverse Cholesterol Transport StudyNCT01670968 · collaborator · 2009-09-01
UNKNOWNSponsor roles
lead sponsor15
collaborator11
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.